Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity-Reference-Cited by-同舟云学术

Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity

Published:2015-11-02 Issue:1 Volume:17 Page:87-94
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Adams Jarrett J,Narayanan Samanthi,Birnbaum Michael E,Sidhu Sachdev S,Blevins Sydney J,Gee Marvin H,Sibener Leah V,Baker Brian M,Kranz David M,Garcia K Christopher

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.3310.pdf

Reference54 articles.

1. Adams, J.J. et al. T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. Immunity 35, 681–693 (2011).

2. Rossjohn, J. et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33, 169–200 (2015).

3. Beringer, D.X. et al. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex. Nat. Immunol. 16, 1153–1161 (2015).

4. Dai, S. et al. Crossreactive T cells spotlight the germline rules for αβ T cell-receptor interactions with MHC molecules. Immunity 28, 324–334 (2008).

5. Feng, D., Bond, C.J., Ely, L.K., Maynard, J. & Garcia, K.C. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat. Immunol. 8, 975–983 (2007).

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-cell virtuosity in ‘‘knowing thyself”;Frontiers in Immunology;2024-02-13

2. BATMAN: Improved T cell receptor cross-reactivity prediction benchmarked on a comprehensive mutational scan database;2024-01-25

3. Discovery of T Cell Epitopes for Cancer Immunotherapy;Interdisciplinary Cancer Research;2024

4. Cellular and molecular imaging of CAR-T cell-based immunotherapy;Advanced Drug Delivery Reviews;2023-12

5. T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome;Nature Reviews Drug Discovery;2023-10-27